Nifty

:

19674.25

Sensex

:

66009.15

-68.10 (-0.34%)
-221.09 (-0.33%)

Login

Nifty
Sensex

:
:

19674.25
66009.15

-68.10 (-0.34%)
-221.09 (-0.33%)

Novartis India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

61/99

BSE: 500672 | NSE: NOVARTIND

Watchlist

NSE BSE

737.75

21-Sep-2023

Open
High
Low
Previous Close

733.20
742.90
731.00
737.55

Volume
Traded Value (lacs)
52 Week High
52 Week Low

13913
102.58
909.00
537.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,814.16
25.47
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,258.22
6.46%
2.28

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-7.90
-5.05
-0.23

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
39.91
20.43

PAT CAGR (%)

10 Years
5 Years
3 Years

0.48
14.83
70.37

P:E (Median)

8 Years
5 Years
3 Years

31.64
49.71
53.10

P:BV (Average)

8 Years
5 Years
3 Years

2.31
2.31
2.37

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.83
14.40
16.50

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 23 Jun 22 Var% Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var%
Net Sales 90.60 120.92 -25.07% 76.13 98.32 -22.57% 80.17 98.96 -18.99% 101.52 104.48 -2.83%
Expenses 73.28 89.12 -17.77% 66.81 92.70 -27.93% 72.53 92.40 -21.50% 85.20 97.39 -12.52%
EBITDA 17.32 31.80 -45.53% 9.32 5.62 65.84% 7.64 6.56 16.46% 16.32 7.09 130.18%
EBIDTM 19.12% 26.30% 12.24% 5.72% 9.53% 6.63% 16.08% 6.79%
Other Income 12.47 26.52 -52.98% 16.37 14.31 14.40% 8.36 6.04 38.41% 6.86 6.38 7.52%
Interest 0.46 0.50 -8.00% 0.30 0.33 -9.09% 0.46 1.46 -68.49% 0.49 1.50 -67.33%
Depreciation 1.56 1.30 20.00% 2.08 1.31 58.78% 1.30 2.75 -52.73% 1.38 2.68 -48.51%
PBT 27.77 56.52 -50.87% 23.31 -31.35 - 14.24 8.39 69.73% 21.31 9.29 129.39%
Tax 7.51 4.14 81.40% -1.71 -7.98 - 6.63 2.04 225.00% 2.96 2.27 30.40%
PAT 20.26 52.38 -61.32% 25.02 -23.37 - 7.61 6.35 19.84% 18.35 7.02 161.40%
PATM 22.36% 43.32% 32.86% -23.77% 9.49% 6.42% 18.08% 6.72%
EPS 8.20 21.21 -61.34% 10.13 -9.46 - 3.08 2.57 19.84% 7.43 2.84 161.62%

Description Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 348.42 378.74 399.87 381.35 438.25 490.68 563.89 656.22 689.77 873.38 862.23 Net Sales Growth -17.57% -5.28% 4.86% -12.98% -10.69% -12.98% -14.07% -4.86% -21.02% 1.29% Cost Of Goods Sold 196.98 201.69 178.14 146.61 182.32 198.65 245.51 306.10 286.31 349.02 386.65 Gross Profit 151.44 177.05 221.73 234.74 255.93 292.03 318.38 350.12 403.46 524.36 475.58 GP Margin 43.46% 46.75% 55.45% 61.56% 58.40% 59.52% 56.46% 53.35% 58.49% 60.04% 55.16% Total Expenditure 297.82 313.66 373.12 355.66 426.51 478.54 572.12 631.70 658.95 881.18 865.65 Power & Fuel Cost - 0.35 0.53 0.53 1.27 1.79 2.56 1.77 4.43 4.87 4.02 % Of Sales - 0.09% 0.13% 0.14% 0.29% 0.36% 0.45% 0.27% 0.64% 0.56% 0.47% Employee Cost - 35.64 101.89 108.51 113.87 117.11 144.53 139.30 156.66 200.03 174.19 % Of Sales - 9.41% 25.48% 28.45% 25.98% 23.87% 25.63% 21.23% 22.71% 22.90% 20.20% Manufacturing Exp. - 15.51 34.49 36.52 39.23 42.21 42.07 49.03 62.35 98.47 104.52 % Of Sales - 4.10% 8.63% 9.58% 8.95% 8.60% 7.46% 7.47% 9.04% 11.27% 12.12% General & Admin Exp. - 19.10 18.61 12.95 23.40 43.28 45.74 45.74 47.65 64.48 62.19 % Of Sales - 5.04% 4.65% 3.40% 5.34% 8.82% 8.11% 6.97% 6.91% 7.38% 7.21% Selling & Distn. Exp. - 27.98 35.66 39.77 53.99 60.29 72.48 75.83 70.74 131.14 101.63 % Of Sales - 7.39% 8.92% 10.43% 12.32% 12.29% 12.85% 11.56% 10.26% 15.02% 11.79% Miscellaneous Exp. - 13.39 3.80 10.77 12.43 15.21 19.23 13.93 30.81 33.17 101.63 % Of Sales - 3.54% 0.95% 2.82% 2.84% 3.10% 3.41% 2.12% 4.47% 3.80% 3.76% EBITDA 50.60 65.08 26.75 25.69 11.74 12.14 -8.23 24.52 30.82 -7.80 -3.42 EBITDA Margin 14.52% 17.18% 6.69% 6.74% 2.68% 2.47% -1.46% 3.74% 4.47% -0.89% -0.40% Other Income 44.06 58.11 33.55 34.19 36.43 78.40 173.81 71.52 244.55 111.58 97.24 Interest 1.71 1.75 4.83 7.68 6.39 1.59 5.53 0.72 0.21 0.21 0.27 Depreciation 6.32 6.06 9.65 12.16 13.14 3.18 2.53 3.59 3.49 4.01 3.65 PBT 86.63 115.38 45.82 40.04 28.64 85.77 157.52 91.73 271.67 99.56 89.90 Tax 15.39 12.02 -0.10 19.14 18.56 34.00 79.16 34.51 73.38 14.12 -8.63 Tax Rate 17.77% 10.42% 2.62% 47.80% 64.80% 39.64% 50.25% 37.62% 27.01% 15.15% -9.60% PAT 71.24 103.36 -3.72 20.90 10.08 51.77 78.36 57.22 198.29 79.11 98.53 PAT before Minority Interest 71.24 103.36 -3.72 20.90 10.08 51.77 78.36 57.22 198.29 79.11 98.53 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 20.45% 27.29% -0.93% 5.48% 2.30% 10.55% 13.90% 8.72% 28.75% 9.06% 11.43% PAT Growth 68.10% - - 107.34% -80.53% -33.93% 36.95% -71.14% 150.65% -19.71% EPS 28.84 41.85 -1.51 8.46 4.08 20.96 31.72 23.17 80.28 32.03 39.89

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 775.66 691.70 711.19 720.73 759.19 733.64 919.64 1,193.58 1,001.99 961.35 Share Capital 12.34 12.34 12.34 12.34 12.34 12.34 14.07 15.98 15.98 15.98 Total Reserves 763.36 681.58 701.80 711.68 751.10 727.48 913.00 1,184.54 986.01 945.37 Non-Current Liabilities 1,007.77 984.00 1,130.65 99.38 891.47 897.75 827.53 26.47 696.64 585.68 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 998.39 991.58 1,109.57 65.93 909.70 916.30 844.46 45.85 714.94 600.01 Current Liabilities 268.26 334.47 357.26 416.93 367.22 481.74 323.21 204.49 361.82 458.91 Trade Payables 59.67 72.20 55.20 72.60 91.40 106.11 73.22 69.66 94.52 107.52 Other Current Liabilities 38.03 45.34 69.64 132.99 67.62 184.52 63.26 88.94 52.24 47.58 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 170.56 216.93 232.42 211.34 208.20 191.11 186.73 45.89 215.06 303.81 Total Liabilities 2,051.69 2,010.17 2,199.10 1,237.04 2,017.88 2,113.13 2,070.38 1,424.54 2,060.45 2,005.94 Net Block 19.25 23.65 63.91 76.28 14.98 4.60 5.71 6.48 8.50 7.87 Gross Block 38.92 40.71 74.81 85.08 23.93 12.09 10.82 9.87 26.08 23.98 Accumulated Depreciation 19.67 17.06 10.90 8.80 8.95 7.49 5.11 3.39 17.58 16.11 Non Current Assets 1,265.59 1,183.39 1,276.75 239.77 1,029.20 1,008.86 958.91 160.85 845.95 698.16 Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.45 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.03 Long Term Loans & Adv. 1,240.75 1,148.65 1,186.01 137.84 989.61 979.98 935.98 153.29 837.20 690.13 Other Non Current Assets 5.59 11.09 26.83 25.65 24.61 24.28 17.21 0.63 0.24 0.13 Current Assets 786.06 825.87 922.35 997.27 988.68 1,104.27 1,111.47 1,263.69 1,214.50 1,307.78 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 54.72 57.07 47.95 58.68 60.51 56.56 87.52 72.40 99.94 103.59 Sundry Debtors 36.16 44.56 38.73 37.60 45.59 43.91 40.83 50.17 82.90 77.40 Cash & Bank 555.94 517.63 498.88 581.91 612.02 775.08 815.72 1,125.55 838.55 16.81 Other Current Assets 139.24 15.49 46.30 59.09 270.56 228.72 167.40 15.57 193.11 1,109.98 Short Term Loans & Adv. 123.29 191.12 290.49 259.99 236.02 202.29 146.86 9.99 190.34 1,109.75 Net Current Assets 517.80 491.40 565.09 580.34 621.46 622.53 788.26 1,059.20 852.68 848.87 Total Assets 2,051.65 2,009.26 2,199.10 1,237.04 2,017.88 2,113.13 2,070.38 1,424.54 2,060.45 2,005.94

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 44.80 38.67 -69.21 -23.14 -194.28 160.99 -40.83 56.59 -59.59 -4.56 PBT 115.38 -3.82 40.04 28.64 85.77 157.52 91.73 111.37 99.56 89.90 Adjustment -48.92 -5.64 -4.98 -11.80 -72.66 -55.87 -55.95 -67.04 -84.63 -74.44 Changes in Working Capital -24.00 66.72 -69.08 -1.85 -161.76 117.30 -32.45 91.70 -31.81 10.76 Cash after chg. in Working capital 42.46 57.26 -34.02 14.99 -148.65 218.95 3.33 136.03 -16.88 26.22 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 2.34 -18.59 -35.19 -38.13 -45.63 -57.96 -44.16 -79.44 -36.38 -30.78 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -6.33 0.00 Cash From Investing Activity -153.25 87.04 95.16 55.91 274.23 68.70 423.64 -630.47 718.94 22.16 Net Fixed Assets 1.79 34.10 10.27 -61.15 -11.84 -1.26 -0.51 15.76 -2.10 2.03 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.00 Others -155.04 52.94 84.89 117.06 286.07 69.96 424.15 -646.24 721.02 20.13 Cash from Financing Activity -30.48 -35.63 -36.80 -41.41 -29.82 -267.65 -331.80 -38.57 -37.67 -37.79 Net Cash Inflow / Outflow -138.93 90.08 -10.85 -8.64 50.13 -37.96 51.01 -612.45 621.68 -20.19 Opening Cash & Equivalents 158.35 68.27 79.12 87.76 37.63 75.59 24.58 637.03 15.35 35.54 Closing Cash & Equivalent 19.42 158.35 68.27 79.12 87.76 37.63 75.59 24.58 637.03 15.35

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 314.30 281.17 289.36 293.36 309.34 299.76 329.45 375.63 313.51 300.80 ROA 5.09% -0.18% 1.22% 0.62% 2.51% 3.75% 3.27% 11.38% 3.89% 4.98% ROE 14.07% -0.53% 2.91% 1.36% 6.89% 9.40% 5.38% 18.01% 8.06% 10.59% ROCE 15.96% 0.14% 6.67% 4.73% 11.70% 19.72% 8.75% 24.77% 9.52% 9.69% Fixed Asset Turnover 11.55 8.43 5.68 9.77 32.72 59.76 63.43 38.38 34.93 34.80 Receivable days 32.03 31.23 30.70 28.50 27.72 22.59 25.31 35.20 33.46 33.71 Inventory Days 44.36 39.38 42.89 40.83 36.25 38.41 44.47 45.59 42.48 45.08 Payable days 119.32 130.52 159.09 74.34 84.28 68.27 44.09 50.69 46.89 53.76 Cash Conversion Cycle -42.92 -59.90 -85.49 -5.01 -20.31 -7.27 25.70 30.10 29.04 25.04 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 66.93 0.21 6.21 5.48 54.94 29.48 128.40 1294.67 444.95 333.96

Top Investors:

investor education and protection fund (iepf)

Annual Reports:

News Update:

Novartis - Quarterly Results
26th Jul 2023, 14:52 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback